Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.940
+0.070 (2.44%)
Aug 4, 2025, 11:48 AM - Market open
ANSYS Market Cap
Grace Therapeutics has a market cap or net worth of $40.66 million as of August 4, 2025. Its market cap has increased by 42.75% in one year.
Market Cap
40.66M
Enterprise Value
17.55M
1-Year Change
42.75%
Ranking
Category
Stock Price
$2.94
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $40.66M, a decrease of -53.38%. That is a compound annual growth rate of -5.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 39.69M | 4.65% |
| Dec 31, 2024 | 37.92M | 39.61% |
| Dec 29, 2023 | 27.16M | 21.53% |
| Dec 30, 2022 | 22.35M | -59.95% |
| Dec 31, 2021 | 55.80M | 77.21% |
| Dec 31, 2020 | 31.49M | -84.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |